Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.8K
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

227
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
227
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

266
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
266
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

238
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
238
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.3K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.3K
Estimation of k and VD of Aminoglycosides01:20

Estimation of k and VD of Aminoglycosides

214
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
214

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ecological and Mutation-Order Speciation in Senecio.

Molecular ecology·2025
Same author

Evolution and evolvability of rifampicin resistance across the bacterial tree of life.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

A unifying principle for multispecies coexistence under resource fluctuations.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Coexistence Theory for Microbial Ecology, and Vice Versa.

Environmental microbiology·2025
Same author

Microbial Dormancy Supports Multi-Species Coexistence Under Resource Fluctuations.

Ecology letters·2024
Same author

Eco-evolutionary maintenance of diversity in fluctuating environments.

Ecology letters·2023

Related Experiment Video

Updated: Jan 18, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.3K

Optimal antimicrobial dosing combinations when drug-resistance mutation rates differ.

Oscar Delaney1, Andrew D Letten1, Jan Engelstädter1

  • 1School of the Environment, The University of Queensland, St Lucia, Queensland, Australia.

Evolution; International Journal of Organic Evolution
|June 2, 2025
PubMed
Summary

Optimizing antimicrobial drug combinations is crucial to combat resistance. Understanding bacterial mutation rates reveals a power law relationship for ideal drug ratios, potentially improving treatment success.

Keywords:
antimicrobial resistancecombination therapyevolutionary rescuemathematical modelingmicrobial evolutionmutation rates

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.3K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.5K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.6K

Area of Science:

  • Microbiology
  • Pharmacology
  • Mathematical Biology

Background:

  • The escalating crisis of antimicrobial resistance (AMR) necessitates novel strategies to prevent the emergence of resistant bacterial strains.
  • Bacterial mutation rates conferring antimicrobial resistance vary significantly across different drug classes.

Purpose of the Study:

  • To investigate if knowledge of relative mutation rates can optimize the combination dosing of two antimicrobial drugs.
  • To identify mathematical relationships governing optimal drug ratios for maximizing treatment success while minimizing resistance evolution.

Main Methods:

  • Development and application of a mathematical model to simulate bacterial evolution under different drug combination scenarios.
  • Utilizing computer simulations to explore the impact of varying mutation rates on treatment outcomes.

Main Results:

  • A significant linear relationship was identified in log-log space between the optimal drug A:drug B dose ratio and the ratio of their mutation rates.
  • This power law relationship was found to be consistent for both bacteriostatic and bactericidal antimicrobial agents.
  • The findings suggest that relative mutation rates are a key factor in determining optimal combination therapy regimens.

Conclusions:

  • Relative mutation rates provide a quantifiable basis for optimizing antimicrobial combination therapy.
  • The identified power law relationship offers a predictive tool for designing more effective antimicrobial dosing strategies.
  • Empirical validation of these findings could lead to substantial improvements in clinical treatment protocols and combatting AMR.